VALIDATE Annual Meeting: Day One - 15 September 2021
A week today we will hold the first day of our virtual Annual Meeting 2021, including project reports from recipients of our Pump-Priming grants and our VALIDATE Fellows and an update on VALIDATE from our Network Manager. The programme is:
VALIDATE Network Manager Sam Vermaak will update members about what VALIDATE has achieved over the last four years as well as our plans for the future.
Characterising the cellular immunity and metabolic response to Mycobacterium tuberculosis and Burkholderia pseudomallei in Indian patients for vaccine design (P033)
Prof Chiranjay Mukhopadhyay, Manipal Academy of Higher Education, India
Developing a mouse model of diabetes to evaluate vaccines for TB and melioidosis (P022)
Dr Elena Stylianou, Jenner Institute, University of Oxford, UK
Vaccines to target people with diabetes: characterising the pathways of immune response to M. tuberculosis and B. pseudomallei in people with diabetes compared to non-diabetics (P016)
Patpong Rongkard, Mahidol Oxford Tropical Medicine Research Unit, Thailand/University of Oxford, UK
VALIDATE Fellowship Presentations
Characterising the BCG-induced antibody response to inform the design of improved vaccines against M.tuberculosis, M.leprae and M.bovis
Dr Rachel Tanner, University of Oxford, UK
Early Career Researcher (ECR) Open Forum
This half hour session between VALIDATE Management and VALIDATE ECRs will be an open discussion around what training, career support and topics you would like VALIDATE to run in the future. All Associate and Affiliate members are welcome (indeed encouraged!) to join, as we'd really value your input to make VALIDATE as useful as possible for you all. We will be running one of these sessions at each Annual Meeting day to enable ECRs in all timezones to input into VALIDATE's future.
You can still register and find out more about this day, as well as Days 2 and 3 (in October and November 2021), on the VALIDATE Annual Meeting 2021 webpage.